"Expressão das metaloproteinases MMP-2, MT1-MMP e TIMP-2 e aspectos clinicopatológicos no carcinoma medular da glândula tireóide: implicações prognósticas" / Expression of matrix metalloproteinases MMP-2, TIMP-2 e MT1-MMP and clinicopathologic aspects in medullary thyroid carcinoma: prognostic implications
AUTOR(ES)
Beatriz Godoi Cavalheiro
DATA DE PUBLICAÇÃO
2006
RESUMO
Metalloproteinases (MMP) are proteolytic enzymes, fundamental to carcinogenesis. Outcome of 37 patients operated on due to medullary thyroid carcinomas were compared to clinicopathologic data and immunohistochemistry expression of MMP-2, MT1-MMP and TIMP-2 in their neoplastic specimens. Final clinical conditions were related to the clinicopathologic aspects: clinical features, systemic symptoms, tumor size, tumor extension to thyroid capsule, tumor extension to adjacent tissues, vascular invasion, cervical metastases, TNM stage and evidences of disease in the neck and/or distant metastases. Expression of MMP-2 and MT1-MMP were related to outcome and greater proportion of TIMP-2, over MMP-2, was related to prognostic benefits
ASSUNTO(S)
carcinoma medullary gelatinase a carcinoma medular metalloproteases imunohistoquímica neoplasias da glândula tireóide prognóstico prognosis immunohistochemistry tissue inhibitor of metalloproteinase-2 gelatinase a thyroid neoplasms metaloproteases inibidor de metaloproteinase-2 tecidual
Documentos Relacionados
- Análise da expressão de MMP-2, MMP-9, MT1-MMP (MMP-14), TIMP-1, TIMP-2, RECK, TGF-Beta e interleucina-8 em câncer de próstata
- Graduação histológica e expressão de metaloproteinases (MMP-9 e MMP-2) e seus inibidores (TIMP-1 e TIMP-2) na glândula mamária canina neoplásica
- Underexpression of MMP-2 and its regulators, TIMP2, MT1-MMP and IL-8, is associated with prostate cancer
- ImunoexpressÃo de metaloproteinases 2 e 14 e do inibidor TIMP-2 no cÃncer colorretal
- MT1-MMP, MMP-2, MMP-9, TIMP-1,-2,-3 and the cell proliferation in the odontogenic region of the incisor tooth of adult rats : effects of doxycycline in the accelerated cell proliferation condition